These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2563612)

  • 1. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
    Zachariae H; Halkier-Sørensen L; Heickendorff L
    Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
    Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of type I and III collagen and hyaluronan in scleroderma skin.
    Søndergaard K; Heickendorff L; Risteli L; Risteli J; Zachariae H; Stengaard-Pedersen K; Deleuran B
    Br J Dermatol; 1997 Jan; 136(1):47-53. PubMed ID: 9039294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma endothelin and the aminoterminal propeptide of type III procollagen (PIIINP) in systemic sclerosis.
    Zachariae H; Heickendorff L; Bjerring P; Halkier-Sørensen L; Søndergaard K
    Acta Derm Venereol; 1994 Sep; 74(5):368-70. PubMed ID: 7817674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
    Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
    Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I
    J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin scoring in systemic sclerosis: a modification--relations to subtypes and the aminoterminal propeptide of type III procollagen (PIIINP).
    Zachariae H; Bjerring P; Halkier-Sørensen L; Heickendorff L; Søndergaard K
    Acta Derm Venereol; 1994 Nov; 74(6):444-6. PubMed ID: 7701875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
    Bolarin DM; Swerdlow P; Wallace AM; Littsey L
    Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H; Søgaard H; Heickendorff L
    Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis.
    Heickendorff L; Zachariae H; Bjerring P; Halkier-Sørensen L; Søndergaard K
    J Am Acad Dermatol; 1995 Apr; 32(4):584-8. PubMed ID: 7896946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
    Scheja A; Akesson A; Hørslev-Petersen K
    Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
    Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
    Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propeptide levels of procollagen type IV (NC1) and III (PIIINP) in patients undergoing haemodialysis.
    Keller F; Dingeldein K; Ser YL; Schuppan D
    Int Urol Nephrol; 1993; 25(3):305-8. PubMed ID: 8225832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
    Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
    Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
    Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology.
    Jensen LT
    Dan Med Bull; 1997 Feb; 44(1):70-8. PubMed ID: 9062765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse disease.
    Scheja A; Hellmer G; Wollheim FA; Akesson A
    Br J Rheumatol; 1993 Jan; 32(1):59-62. PubMed ID: 8422562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.